Ribonuclease and its inhibitor in red blood cells in CF
Bardoń, A.; Ceder, O.; Kollberg, H.
Acta Universitatis Carolinae. Medica 36(1-4): 73-74
1990
ISSN/ISBN: 0001-7116 PMID: 2130725 Document Number: 359530
A disturbed activity of ribonuclease (RNAase) and its natural inhibitor was found in cystic fibrosis patients (CF); Heterozygotes had normal RNAase but increased inhibitor activities; both groups compared with age-matched controls. RNAase is involved in the breakdown of RNA. In the cell it is bound to an inhibitor and thus inactive (Bardoń 1976). Quantitative and qualitative differences of RNAase are found in CF (reviewed in Bardoń 1987).
Document emailed within 1 workday
Related Documents
Okamoto, Y.; Nakabayashi, H.; Kikukawa, S.; Nakano, H. 1996: Detection of p27/kip1 mRNA in blood cells by nonradioactive ribonuclease protection assay Rinsho Byori. Japanese Journal of Clinical Pathology 44(5): 483-486Shapiro, R. 2001: Cytoplasmic ribonuclease inhibitor Methods in Enzymology 341: 611-628
Malkovský, M.; Asherson, G.L.; Chandler, P.; Colizzi, V.; Watkins, M.C.; Zembala, M. 1983: Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells Journal of Immunology 130(2): 785-790
Schneider, R.; Schneider-Scherzer, E.; Thurnher, M.; Auer, B.; Schweiger, M. 1988: The primary structure of human ribonuclease/angiogenin inhibitor (RAI) discloses a novel highly diversified protein superfamily with a common repetitive module EMBO Journal 7(13): 4151-4156
Noyer, M.; Schnek, A.G.; Léonis, J. 1975: Catalytic titration in solution of ribonuclease and oxidized ribonuclease. Distribution of radioactivity among the amino acids Archives Internationales de Physiologie et de Biochimie 83(2): 391-393
Stanĕk, R.; Cinátl, J.; Matousek, J. 1978: The effect of bovine pancreatic ribonuclease (A RNase) and bull seminal ribonuclease (AS RNase) on human lymphocytes undergoing blastic transformation Folia Biologica 24(2): 111-117
Sprengers, E.D.; Akkerman, J.W.; Jansen, B.G. 1986: Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood Thrombosis and Haemostasis 55(3): 325-329
Weiss, L.; Sinks, L.F. 1970: The elekctrokinetic surfaces of human cells of lymphoid origin and their ribonuclease susceptibility Cancer Research 30(1): 90-94
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816
Cinatl, J.; Cinatl, J.; Kotchetkov, R.; Matousek, J.; Woodcock, B.G.; Koehl, U.; Vogel, J.U.; Kornhuber, B.; Schwabe, D. 2000: Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs Anticancer Research 20(2a): 853-859
Krechetova, G.D.; Sukhova, T.I. 1980: Ribonuclease activity of ribosomes and nucleoli in experimental hepatomas and liver cells of healthy and tumor-bearing animals Vestnik Akademii Meditsinskikh Nauk SSSR 6: 64-67
Cholewa, L.; Magdoń, M.; Mruk, K.; Sznajd, J. 1972: Ribonuclease (RNase) activity in blood serum of patients with myocardial infarction. I. The changes of activity during first three days of the disease Przeglad Lekarski 29(5): 534-541
Matsumoto, U.; Shibusawa, Y. 1986: Surface affinity chromatographic separation of blood cells. V. Retention behaviour of human peripheral blood cells on poly(propylene glycol) bonded agarose columns and its relationship to surface hydrophobicities of the gel beads and the cells Journal of Chromatography 356(1): 27-36
Steven, F.S.; Johnson, J.; Eason, P. 1993: A protein inhibitor, extracted from Hela cells, which recognises a cell surface protease on preneoplastic cells obtained from cervical smears Anticancer Research 13(4): 1059-1061
Galvão, M.; Sabbaga, E. 1988: Transfusion and transplantation. Aged (senescent) red blood cells and young red blood cells (neocytes)--transfusional properties Amb: Revista da Associacao Medica Brasileira 34(6): 193-195
Buus, S.; Werdelin, O. 1986: A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells Journal of Immunology 136(2): 452-458
Laurell, M.; Stenflo, J. 1989: Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thrombosis and Haemostasis 62(3): 885-891
Bjercke, S.; Braathen, L.; Gaudernack, G.; Thorsby, E. 1985: Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells Acta Dermato-Venereologica 65(5): 374-378
Koubek, K.; Herzog, P.; Libánsky, J. 1980: Separation of blood cells from normal blood and blood of patients with various malignant blood diseases using separation media Folia Haematologica 107(1): 41-53
Roger, V.; Brennhovd, I.; Hoeg, K. 1972: Tumor cells in blood: the prognostic significance of tumor cells in blood during palpation and biopsy Acta Cytologica 16(6): 557-560